Suppr超能文献

用于急性坏死性胰腺炎中持续动脉输注蛋白酶抑制剂的血管通路系统。

Vascular access system for continuous arterial infusion of a protease inhibitor in acute necrotizing pancreatitis.

作者信息

Ganaha F, Yamada T, Yorozu N, Ujita M, Irie T, Fukuda Y, Fukuda K, Tada S

机构信息

Department of Radiology, Jikei University School of Medicine, Aoto Hospital, 6-41-2 Aoto, Katsushika-ku, Tokyo 125-8506, Japan.

出版信息

Cardiovasc Intervent Radiol. 1999 Sep-Oct;22(5):436-8. doi: 10.1007/s002709900423.

Abstract

We used a vascular access system (VAS) for continuous arterial infusion (CAI) of a protease inhibitor in two patients with acute necrotizing pancreatitis. The infusion catheter was placed into the dorsal pancreatic artery in the first patient and into the gastroduodenal artery in the second, via a femoral artery approach. An implantable port was then connected to the catheter and was secured in a subcutaneous pocket prepared in the right lower abdomen. No complications related to the VAS were encountered. This system provided safe and uncontaminated vascular access for successful CAI for acute pancreatitis.

摘要

我们对两名急性坏死性胰腺炎患者使用了血管通路系统(VAS)进行蛋白酶抑制剂的持续动脉输注(CAI)。通过股动脉途径,将输注导管置入第一名患者的胰背动脉和第二名患者的胃十二指肠动脉。然后将植入式端口连接到导管,并固定在右下腹制备的皮下袋中。未遇到与VAS相关的并发症。该系统为急性胰腺炎的成功CAI提供了安全且无污染的血管通路。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验